about
Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study.Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.Reduced bone mineralization in adolescent survivors of malignant bone tumors: comparison of quantitative ultrasound and dual-energy x-ray absorptiometry.Il6 gene promoter polymorphism (-174G/C) influences the association between fat mass and cardiovascular risk factors.Hypoglycaemia and Russell-Silver syndrome.No evidence of association between the serotonin 2A receptor--1438G/A promoter polymorphism and childhood obesity in a Spanish population: A case-parent study and a matched case-control study.Effect of long-term growth hormone treatment on final height of children with Russell-Silver syndrome.A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population.Chemotherapy-induced growth hormone deficiency in children with cancerSerum Amyloid A Concentration is Increased in Obese Children and AdolescentsAssociation between obesity and insulin resistance with UCP2–UCP3 gene variants in Spanish children and adolescentsGene–gene interaction between PPARγ2 and ADRβ3 increases obesity risk in children and adolescents[Second tumors in pediatric oncologic patients. Report of 5 cases]Partial splenic embolization in a child with hereditary spherocytosisUse of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesisGrowth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotypeHeight and weight achievement in cleft lip and palate[Obesity in children]Adrenal suppression in children with malignant solid tumors treated with megestrol acetateAbsence of catch-down growth in Russell-Silver syndrome after short-term growth hormone treatmentGrowth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation/Russell-Silver syndromeGrowth hormone treatment of russell-silver syndromeMultiple neonatal endocrinopathies in McCune-Albright syndromeFat mass by air-displacement plethysmography and impedance in obese/non-obese children and adolescentsNormal neurological outcome after congenital thyrotoxicosis: prognostic value of observation of general movementsAssociations of telomere length with two dietary quality indices after a lifestyle intervention in children with abdominal obesity: a randomized controlled trial
P50
Q30884970-63E382FD-3A94-47F6-897C-5E1A0EE7589FQ38297297-7FC9E5E7-3708-47B4-8168-4F339AE5E2E8Q39646388-7A4559B7-A076-406C-8F6B-423275BB4AEFQ43112485-335FE3A2-A5EB-48EA-8D89-3E8716A9CB50Q46674603-A40F9B57-80C2-42DA-983D-D6A5A730AC15Q46955103-FCBFCA1D-EBD0-4B32-B3CB-7F846D020047Q47434417-E5EAF6B6-95E3-49A3-9C90-FD4C9381270AQ51753742-43C8F351-1690-4C4F-9CC8-32A14BB52C9AQ57222106-9459F3E5-B3C1-4140-BC25-BBBB42390DF3Q58074936-5E00B936-E6AD-4D9F-86DF-C24A5C9E6117Q58074954-8A0059A1-C742-42CB-A706-85A68196DCB3Q58075052-9C31C123-980E-433E-AE2E-6CBBC28BD561Q71767212-64B3EF23-EC6A-424B-B6E8-D24D33A0D5E6Q72051836-5354B926-BE37-403B-B47B-955D42DD40FDQ72415986-80479148-4DDD-41E0-99F4-74A6C66DE942Q73321727-D03ADA4D-9C94-468E-A9E9-632054A42D1AQ73707241-C06F0F7B-907D-44B2-95D6-29569E9B7BDAQ73846617-86C2EB44-B0A6-4732-9BE9-E8A31BF35F81Q73985970-AF5DD177-3822-4855-B30E-68CCBEF5E7ACQ74645785-3BE5EDEE-EC64-460B-917B-FDBA3545EC23Q74837665-0C5C180C-79AF-4E6B-A5DE-1BCF0722BA3DQ77146780-0ADFFB17-3B43-4307-A949-736178A8E4B2Q77996448-9BB57567-881E-40DA-B7ED-5C60254A02C7Q81361062-504DB63C-227D-4F92-AE8D-F3EDE19EFF73Q84150665-20722DDB-A105-42FF-AC8C-A96B3F3F5B14Q96586986-9FF457EE-A412-4791-8ED3-48C73F18F9BA
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cristina Azcona
@ast
Cristina Azcona
@en
Cristina Azcona
@es
Cristina Azcona
@nl
type
label
Cristina Azcona
@ast
Cristina Azcona
@en
Cristina Azcona
@es
Cristina Azcona
@nl
prefLabel
Cristina Azcona
@ast
Cristina Azcona
@en
Cristina Azcona
@es
Cristina Azcona
@nl
P106
P21
P31
P496
0000-0001-5534-8758